mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-05 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-05 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
4e-05 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-05 |